Covid-19 Long Haul Preventative and Health Promotion Care Clinical Trial Acceleration Program.
Public ClinicalTrials.gov record NCT06441955. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Covid-19 Long Haul Syndrome: Undiagnosed Disorder Post Covid-19 Alternative Treatment Study.
Study identification
- NCT ID
- NCT06441955
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Well- Konnect Healthcare Services and Research Firm
- Network
- Enrollment
- 100 participants
Conditions and interventions
Conditions
Interventions
- Behavioral (e.g., Psychotherapy, Lifestyle Counseling) Behavioral
- Biopsychological Behavioral
- Genetic (including gene transfer, stem cell and recombinant DNA) Genetic
- Moderna COVID-19 Vaccine Biological
- Multidisciplinary approach Combination Product
- Physiological Evaluation Diagnostic Test
- Ritonavir-Boosted Nirmatrelvir (Paxlovid) Drug
Behavioral · Genetic · Biological + 3 more
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 29, 2024
- Primary completion
- Sep 29, 2030
- Completion
- Sep 29, 2030
- Last update posted
- Nov 26, 2024
2024 – 2030
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| NIH Clinical Center | Bethesda | Maryland | 20892 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06441955, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 26, 2024 · Synced Apr 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06441955 live on ClinicalTrials.gov.